Previous alloimmunization may increase risks during stem cell transplants
Children who have previously experienced alloimmunization may be at increased risk of complications during stem cell transplants.
Children who have previously experienced alloimmunization may be at increased risk of complications during stem cell transplants.
Researchers developed and validated a retrospective method for accurately identifying cases of HDFN to better understand its epidemiology.
Researchers found phototherapy, a common treatment for HDFN, is associated with a slightly higher cancer risk.
A global non-interventional registry study aims to evaluate the risk of anemia in infants who may be at risk of HDFN.
An extensive literature review outlined the current recommendations for hemolytic disease of the fetus and newborn diagnosis and management.
An upcoming study will analyze the prevalence, risk factors and clinical characteristics of neonatal anemia, a common complication of HDFN.
A recent case report described a patient who presented with an uncommon case of HDFN caused by anti-LU1 (anti-Luᵃ) alloantibodies.
Machine learning is a form of AI that may be able to help doctors predict jaundice risk.
Extending delivery at or beyond 34 weeks and performing an IUT around that time could be beneficial in pregnancies complicated with HDFN.
A study found that neonatal hyperbilirubinemia, a common complication of HDFN, is linked to early weight loss during the neonatal period.